Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Commercial

Set Alert for Commercial

Financial Results Explore this Topic

Set Alert for Financial Results

Latest From Financial Results

Eastern European performance hurts Krka in Q1

The animal health division of Slovenian pharmaceutical company Krka returned to a dip in sales during the first quarter of 2018.

Krka Financial Results

Zomedica expansion drives net loss, firm opens private offering

Zomedica Pharmaceuticals has recorded a higher net loss in the first quarter of 2018, as it builds out the company and continues investing in R&D.

North America United States

Animalcare records robust revenues, hits pro-forma growth expectation for 2017

UK animal health firm Animalcare has posted strong revenue growth for 2017, following its merger with Belgian company Ecuphar.

Europe Belgium
See All

M&A Explore this Topic

Set Alert for MandA

Latest From M&A

Tyson to pay $850m for poultry rendering business

Tyson Foods has agreed to buy the poultry rendering and blending assets of American Proteins and AMPRO Products in a deal worth around $850 million.

Tyson Foods M&A

Heska welcomes Schein joint venture with Vets First Choice

The upcoming merger between leading veterinary distributor Henry Schein and Vets First Choice to create a diagnostics subsidiary has been welcomed by rival firm Heska.

North America United States

Zoetis set to acquire diagnostics specialist Abaxis in $2bn deal

Industry leader Zoetis has signed a definitive merger agreement to acquire the second-largest veterinary diagnostics firm Abaxis. 

United States North America
See All

Investments

Set Alert for Investments

Bactana secures significant portion of new equity round

US microbiome discovery firm Bactana Animal Health has received $400,000 in financing from Connecticut Innovations.

Investments Pharmaceuticals

Avivagen to further push commercialization efforts with extra funding

Canadian company Avivagen has sourced Can$800,000 ($626,000) from the credit facility provided by Bloom Burton Healthcare Lending Trust.

Feed & Additives Pharmaceuticals

Biovet invests in expanding facilities, diagnostics capabilities

Canadian veterinary diagnostics company Biovet has begun a Can$2.25 million ($1.75 million) expansion of its headquarters, with construction expected to be completed in July.

North America Canada

TyraTech sales climbing as company goes animal health-only

US parasite control company TyraTech has made progress in ramping up its product sales after it decided to focus solely on animal health.

North America United States

MBFT gains funding to support canine melanoma vaccine

US firm Man's Best Friend Therapeutics (MBFT) has receive $250,000 in funding from Benjamin Franklin Technology Partners.

Vaccines Canine

Heska welcomes Schein joint venture with Vets First Choice

The upcoming merger between leading veterinary distributor Henry Schein and Vets First Choice to create a diagnostics subsidiary has been welcomed by rival firm Heska.

North America United States
See All

Operations Explore this Topic

Set Alert for Operations

Oasmia spin-off to begin US vet oncology commercialization in H2

Swedish firm Oasmia Pharmaceutical has completed the spin-off of its veterinary oncology business into a US subsidiary called AdvaVet.

United States Pharmaceuticals

Anizome to bridge valley of death between microbiome research and commercialization

The first company focused on a commercial therapeutic microbiome discovery platform dedicated to animal health and nutrition has been created.

Pharmaceuticals Companion Animals

Biovet invests in expanding facilities, diagnostics capabilities

Canadian veterinary diagnostics company Biovet has begun a Can$2.25 million ($1.75 million) expansion of its headquarters, with construction expected to be completed in July.

North America Canada
See All

People Explore this Topic

Set Alert for People

Patterson boosts leadership team with senior appointments

US veterinary products distributor Patterson Companies has made two important appointments to enhance its leadership expertise.

People Patterson Companies

Anizome to bridge valley of death between microbiome research and commercialization

The first company focused on a commercial therapeutic microbiome discovery platform dedicated to animal health and nutrition has been created.

Pharmaceuticals Companion Animals

Anatara chairman retires as firm changes focus

Australian firm Anatara Lifesciences has announced its executive chairman Mel Bridges will be retiring.

People Operations
See All
Advertisement
UsernamePublicRestriction

Register